With the recent approval of tolterodine and oxybutynin XL, we believe that the list of agents previously considered first- and second-line medications for the overactive bladder needs to be revised.

Many drugs commonly prescribed to the elderly have anticholinergic properties. Due to the current clinical use of drugs with mild-to-modest anticholinergic activity, the clinical manifestations of ...